Provided by Tiger Trade Technology Pte. Ltd.

NRX Pharmaceuticals Inc.

2.21
+0.07503.52%
Volume:204.08K
Turnover:451.30K
Market Cap:72.91M
PE:-1.65
High:2.24
Open:2.15
Low:2.15
Close:2.13
52wk High:3.84
52wk Low:1.58
Shares:33.07M
Float Shares:24.28M
Volume Ratio:0.34
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3400
EPS(LYR):-2.3605
ROE:-682.61%
ROA:-121.85%
PB:-4.58
PE(LYR):-0.93

Loading ...

NRX Pharmaceuticals Inc: No Additional Clinical Trials Were Requested

THOMSON REUTERS
·
Mar 16

NRX Pharmaceuticals Inc - FDA Confirms No Additional Nonclinical Data or Bridging Studies Required for NRX-100

THOMSON REUTERS
·
Mar 16

NRX Pharmaceuticals Inc expected to post breakeven results a share - Earnings Preview

Reuters
·
Mar 13

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Mar 10

Hope Therapeutics, an NRX Subsidiary (Nasdaq:Nrxp) Announces Opening of Palm Beach, Fl Clinic Offering One Day Treatment for Depression and Ptsd

THOMSON REUTERS
·
Mar 09

HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD

GlobeNewswire
·
Mar 09

NRX Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 04

NRx Pharmaceuticals price target raised to $45 from $40 at H.C. Wainwright

TIPRANKS
·
Mar 03

NRx Pharmaceuticals Names Prof. Joshua Brown Chief Medical Innovation Officer

Reuters
·
Mar 02

NRX Pharmaceuticals (Nasdaq: Nrxp) Appoints Prof. Joshua Brown Md, Phd, as Chief Medical Innovation Officer

THOMSON REUTERS
·
Mar 02

NRX Pharmaceuticals Price Target Maintained With a $25.00/Share by BTIG

Dow Jones
·
Feb 19

NRX Pharmaceuticals Files Initial Beneficial Ownership Statement for Chief Operating Officer Joseph Michael Casper

Reuters
·
Feb 18

NRX Pharmaceuticals Inc - Files Prospectus for $20 Mln Common Stock - SEC Filing

THOMSON REUTERS
·
Feb 17

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Feb 17

BRIEF-Nrx Pharmaceuticals (NasdaqNrxp) Announces Path To New Drug Application With Real World Data

Reuters
·
Feb 17

NRX Pharmaceuticals Advances NRX-100 Toward FDA Approval for Suicidal Depression

Reuters
·
Feb 17

NRX Pharmaceuticals: Will Use Clinical Trial Data in Hand With Proposed Real World Data From Osmind to Apply for NRX-100 Approval

THOMSON REUTERS
·
Feb 17

NRX Pharmaceuticals Inc - Believes Path for NRX-100 Approval Based on Existing Data

THOMSON REUTERS
·
Feb 17

NRX Pharmaceuticals Inc - FDA Advises No Additional Nonclinical Data Needed for NRX Application

THOMSON REUTERS
·
Feb 17

NRX Pharmaceuticals (Nasdaq:Nrxp) Announces Path to New Drug Application With Real World Data and Broader Proposed Indication for NRX-100 (Ketamine) Following Type C FDA Meeting

THOMSON REUTERS
·
Feb 17